The endocrine-oncology research lab is part of the oncology institute. Despite major advances in cancer treatment, cancer is the leading cause of death in the western world, including in Israel. Patients who suffer from metastatic disease are often being treated with chemotherapy, a treatment that can slow the disease but very often cannot cure it. Moreover, chemotherapy is often toxic and is associated with wide array of side effects. Thus, the development of more active and less toxic therapies is of major importance.
Our lab adopted a unique approach in cancer research. Cancer is not an isolated process and its development is tightly associated with endocrine and metabolic changes in the body. By investigating the complex interactions between cancer and metabolic changes we are able to decipher novel endocrine aspects of malignancy and gain new insights into the development of cancer.
The laboratory is located at Tel Aviv Sourasky Medical Center and is equipped with the state of the art equipment. In our work we take advantage of our position within a medical center and combine state of the art technology with clinical data and samples available to us. This proximity also allows us to take interesting clinical observations directly to the lab.